SCHEMBL6220580

SCHEMBL6220580

COc1ccccc1C(=O)NC(c1ccccc1)[C@H]1CC[C@H](N(C)C(N)=NC#N)CC1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KCNA5 P22460 1/20 0.42
KCNA3 P22001 2/20 0.37
CTSD P07339 1/20 0.37
OPRK1 P41145 1/20 0.37
LMNA P02545 1/20 0.36
TACR3 P29371 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KCNK3 O14649 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6218371 1.00 ALDH1A1 (0.44) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL6219641 0.91 MEN1 (0.47) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL5467362 0.86 ALDH1A1 (0.41) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL5474220 0.86 ALDH1A1 (0.41) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL6220387 0.79 KCNA5 (0.39) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL5460016 0.79 ALDH1A1 (0.39) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL3455507 0.77 MEN1 (0.62) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL5345113 0.76 ALDH1A1 (0.41) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL5462253 0.76 THRB (0.40) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL5460021 0.76 THRB (0.40) ALDH1A1HPGDMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1507504-A1 CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-23 EP disclosed
WO-2003063797-A2 CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-08-07 WO disclosed